ArticleJournal of nanobiotechnology2026
An ROS-responsive, RGC-targeted nanotherapeutic strategy with a TRPV4 antagonist restores autophagic flux and protects RGCs in a rat model of chronic ocular hypertension.
Jiarun Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.